Literature DB >> 21550119

Early flap displacement after LASIK.

Gerry Clare1, Tara C B Moore, Claire Grills, Antonio Leccisotti, Johnny E Moore, Steve Schallhorn.   

Abstract

PURPOSE: To evaluate the risks of flap displacement after LASIK.
DESIGN: Retrospective case series. PARTICIPANTS: We included 41 845 consecutive adults who underwent LASIK surgery at Optical Express in the United Kingdom, including 81 238 eyes, of which 14 555 were hyperopic and 66 681 myopic or mixed astigmatic. We treated 57 241 eyes with the IntraLase FS-60 femtosecond laser and 23 997 with the Moria S.A. ONE Use-Plus automated microkeratome.
METHODS: We calculated the incidence of all flap displacements in the study population during an observational time period of ≥12 months after surgery. Independent variables were entered into logistic regression models to identify risk factors. Postoperative outcomes were assessed. MAIN OUTCOME MEASURES: The incidence and odds ratios (OR) of flap displacement in the study population and in categories of refractive error and flap surgery technique.
RESULTS: The incidence of flap displacements was 10 in 81 238 LASIK procedures (0.012%), including 8 hyperopic eyes (0.055%) and 2 myopic eyes (0.003%). All flap displacements occurred within 48 hours of surgery and none were preceded by ocular trauma. They were classified as "early flap displacements" (EFD). The incidence of EFD after microkeratome surgery was 0.033% (n = 8), and after femtosecond laser it was 0.003% (n = 2). In hyperopic eyes having microkeratome surgery, the incidence was 0.179% (n = 7). In a logistic regression model, the strongest predictor of EFD after LASIK was hyperopia, recording an OR of 19.29 (P<0.001). The OR of developing an EFD after microkeratomy was 10.53 times higher than after femtosecond laser (P<0.005). In hyperopes, the OR of an EFD was 18.87 times higher after microkeratomy than after femtosecond treatment. Four of 10 displaced flaps needed secondary surgery, and 1 eye lost 2 lines of best-corrected visual acuity.
CONCLUSIONS: The incidence of flap displacements during a 12-month period after LASIK was extremely low (0.012%). Although the small number of displacements with the femtosecond laser limits conclusions, the risk of EFD was higher after microkeratome surgery than femtosecond laser.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21550119     DOI: 10.1016/j.ophtha.2011.01.053

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

Review 1.  Risk factors and visual results in cases of LASIK flap repositioning due to folds or dislocation: case series and literature review.

Authors:  Virgilio Galvis; Alejandro Tello; Alfredo R Guerra; Juan J Rey; Paul A Camacho
Journal:  Int Ophthalmol       Date:  2013-04-19       Impact factor: 2.031

2.  Rescue of primary incomplete microkeratome flap with secondary femtosecond laser flap in LASIK.

Authors:  E A Razgulyaeva
Journal:  Case Rep Ophthalmol Med       Date:  2014-11-23

3.  Calzone-Like Traumatic Flap Dislocation Four Years after Laser in situ Keratomileusis.

Authors:  Isaak Fischinger; Jascha Wendelstein; Matthias Bolz; Manfred Tetz
Journal:  Case Rep Ophthalmol       Date:  2019-08-13

4.  Management of late traumatic LASIK flap dislocation related to dog scratch 16 Years postoperatively.

Authors:  Mario Carranza-Casas; Fabiola Anaya-Barragán; Gabriel Cedillo; Enrique O Graue-Hernández; Alejandro Navas
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-28

5.  LASIK flap stability after severe ocular injury.

Authors:  Timothy Todd; Todd Mondzelewski; John Cason; Elizabeth Hofmeister; Stephen O'Connell; Christopher Richmond
Journal:  Am J Ophthalmol Case Rep       Date:  2020-01-30

Review 6.  Complications of laser-assisted in situ keratomileusis.

Authors:  Pranita Sahay; Rahul Kumar Bafna; Jagadesh C Reddy; Rasik B Vajpayee; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2021-07       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.